A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements.
Ontology highlight
ABSTRACT: Theranostics is the combination of two approaches-diagnostics and therapeutics-applied for decades in cancer imaging using radiopharmaceuticals or paired radiopharmaceuticals to image and selectively treat various cancers. The clinical use of theranostics has increased in recent years, with U.S. Food and Drug Administration (FDA) approval of lutetium 177 (177Lu) tetraazacyclododecane tetraacetic acid octreotate (DOTATATE) and 177Lu-prostate-specific membrane antigen vector-based radionuclide therapies. The field of theranostics has imminent potential for emerging clinical applications. This article reviews critical areas of active clinical advancement in theranostics, including forthcoming clinical trials advancing FDA-approved and emerging radiopharmaceuticals, appro
SUBMITTER: Burkett BJ
PROVIDER: S-EPMC10413300 | biostudies-literature | 2023 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA